CPhI South Korea Korea positioned to be global biopharma powerhouse, says industry association 25-Aug-2016 By Dan Stanton Stem cells and biosimilars are driving the Korean pharma market, according to the country’s Biomedicine Industry Association KoBIA.
Janssen averse to extrapolation as FDA sits to review Remicade biosimilar 09-Feb-2016 By Dan Stanton Celltrion’s CT-P13 has been declared “highly similar” in safety and efficacy to J&J’s Remicade, and could be recommended for approval by a US FDA committee today.